Table 4.
Variable | Reference level | IRR [95% CI] |
---|---|---|
Testing site POC/Lab | PST | 1.65* [1.47, 1.84] |
Age at index | NA | 0.99* [0.99, 0.99] |
Payer channel Medicare | Commercial | 1.39* [1.32, 1.47] |
Male | Female | 0.81* [0.78, 1.84] |
Hypertension | No hypertension | 1.11* [1.07, 1.16] |
Heart failure | No heart failure | 1.14* [1.09, 1.20] |
Valvular disease | No valvular disease | 0.96* [0.92, 1.00] |
Diabetes | No diabetes | 1.14* [1.10, 1.19] |
Chronic pulmonary disease | No chronic pulmonary disease | 1.22* [1.17, 1.28] |
Renal disease | No renal disease | 1.35* [1.28, 1.43] |
Peripheral vascular disease | Peripheral vascular disease | 1.11* [1.06, 1.17] |
Cancer | No cancer | 1.26* [1.19, 1.33] |
Obesity | No obesity | 1.15* [1.10, 1.20] |
IRR, incidence rate ratio. Statistically significant effects (i.e., p < .05) are indicated by *. Age at index included as a continuous variable